TAGGER, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 7.743
NA - Nord America 5.814
AS - Asia 5.554
SA - Sud America 510
AF - Africa 99
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 19.733
Nazione #
US - Stati Uniti d'America 5.614
GB - Regno Unito 3.683
SG - Singapore 1.733
CN - Cina 1.620
IT - Italia 949
RU - Federazione Russa 755
SE - Svezia 502
TR - Turchia 463
HK - Hong Kong 436
VN - Vietnam 421
UA - Ucraina 395
DE - Germania 378
BR - Brasile 348
KR - Corea 314
FR - Francia 313
IE - Irlanda 252
IN - India 246
NL - Olanda 200
FI - Finlandia 177
EU - Europa 166
CA - Canada 143
BD - Bangladesh 93
CO - Colombia 69
AR - Argentina 43
ID - Indonesia 42
GR - Grecia 28
JP - Giappone 28
IQ - Iraq 26
MX - Messico 24
CI - Costa d'Avorio 23
UZ - Uzbekistan 21
PL - Polonia 20
SA - Arabia Saudita 19
ZA - Sudafrica 19
EC - Ecuador 14
PK - Pakistan 13
BE - Belgio 12
ES - Italia 12
PH - Filippine 11
VE - Venezuela 11
MA - Marocco 9
PY - Paraguay 9
AT - Austria 8
DK - Danimarca 8
EG - Egitto 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
AU - Australia 7
KE - Kenya 7
CL - Cile 6
IR - Iran 6
LU - Lussemburgo 6
MY - Malesia 6
DO - Repubblica Dominicana 5
DZ - Algeria 5
JO - Giordania 5
TN - Tunisia 5
UY - Uruguay 5
AO - Angola 4
BY - Bielorussia 4
CH - Svizzera 4
CR - Costa Rica 4
IL - Israele 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LT - Lituania 4
MD - Moldavia 4
AZ - Azerbaigian 3
BO - Bolivia 3
DM - Dominica 3
ET - Etiopia 3
JM - Giamaica 3
LB - Libano 3
NI - Nicaragua 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SO - Somalia 3
AM - Armenia 2
BW - Botswana 2
CD - Congo 2
CZ - Repubblica Ceca 2
EE - Estonia 2
GA - Gabon 2
GT - Guatemala 2
HN - Honduras 2
KH - Cambogia 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 19.872
Città #
Southend 3.588
Singapore 927
Ashburn 494
Seattle 451
Beijing 446
Chandler 446
San Jose 428
Hong Kong 424
Princeton 312
Jacksonville 279
Dublin 250
Redmond 218
Wilmington 216
Santa Clara 214
Milan 200
Council Bluffs 171
Kent 171
Sakarya 149
Mountain View 144
Bengaluru 141
Lauterbourg 138
Dallas 136
Nanjing 132
Los Angeles 127
Des Moines 122
Ho Chi Minh City 98
Boardman 89
Moscow 89
Buffalo 85
Hanoi 85
Ann Arbor 79
Dearborn 79
Toronto 78
Serra 77
Andover 65
Bogotá 64
Saint Petersburg 59
Shanghai 59
Guangzhou 53
New York 52
Hefei 49
Dong Ket 48
Tianjin 48
Shenyang 47
The Dalles 42
Columbus 41
Ottawa 41
Rome 41
Nanchang 39
Jinan 37
Cangzhou 36
Hanover 33
Woodbridge 33
Berlin 28
Changsha 27
Fuzhou 27
São Paulo 26
Fairfield 25
Hebei 25
Munich 25
Tokyo 25
Frankfurt am Main 24
Abidjan 23
Bitonto 23
Medford 22
Roxbury 22
Shenzhen 22
Athens 20
Houston 19
Da Nang 18
Seoul 18
Chicago 17
San Diego 17
Turin 17
Warsaw 17
Baghdad 15
Hangzhou 14
Helsinki 14
Mumbai 14
Jiaxing 13
Verona 13
Belo Horizonte 12
Brussels 12
Haiphong 12
Kunming 12
Ningbo 12
Palermo 12
Pune 12
Redwood City 12
Somerville 12
Turku 12
Zhengzhou 12
Johannesburg 11
Dhaka 10
London 10
Washington 10
Eitensheim 9
Fremont 9
Grafing 9
Newark 9
Totale 12.749
Nome #
Hepatitis B virus infection in dentists and dental students 367
Prevalence of naturally occurring S-gene mutants of hepatitis B virus in HBsAg negative patients with hepatocellular carcinoma and controls 364
Trasmissione verticale dell’infezione da HBV in bambini sottoposti a immunoprofilassi anti-epatite B 232
Mother-infant transmission of hepatitis B virus (HBV) infection in children receiving full passive and active immunoprophylaxis 232
The ability of Procleix Ultrio assay to detect HBV DNA in HBsAg positive blood donors 223
Occult hepatitis B virus and hepatocellular carcinoma : a case-control study 214
Alcohol dehydrogenase 3, glutathione S-transferase M1 and T1 polymorphisms, alcohol consumption and hepatocellular carcinoma (Italy) 207
A 1-year trial of lamivudine for chronic hepatitis B in children 206
Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis 203
A randomized trial of prolonged high dose of interferon plus ribavirin for hepatitis C patients nonresponders to interferon alone 198
Prevalenza dell'infezione occulta da HBV in donatori di sangue con anti-HBc-Ag isolato vaccinati contro l'epatite B 197
Reinfection of liver graft by hepatitis B virus in transplant recipients with occult hepatitis B 196
Antibodies to hepatitis C virus in blood donors 194
GENOTIPI DELL'HCV IN PAZIENTI SOTTOPOSTI A TRAPIANTO DI FEGATO PER EPATOCARCINOMA SU CIRROSI 194
Mutations within the CD81-binding sites and hypervariable region 2 of the envelope 2 protein and hepatitis C recurrence after liver transplantation 193
A multicenter controlled, randomized, open trial of interferon alpha2b treatment of anti-human immunodeficiency virus-negative hemophilic patients with chronic hepatitis C 188
Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy 185
Occult hepatitis B in patients with hepatocellular carcinoma and controls with and without hepatitis C infection 182
Maternal-infant transmission of HCV infection 182
Maternal-infant transmission of hepatitis C virus and HIV infections: a possible interaction 182
Polimorfismi genetici degli enzimi N-acetiltransferasi 2 e glutatione-s-transferasi, fumo di tabacco e rischio di epatocarcinoma 181
Analisi dei donatori di sangue RIBA HCV indeterminati con l'uso di peptidi sintetici 180
N-Acetyltransferase-2, glutathione S-transferase M1 and T1 genetic polymorphisms, cigarette smoking and hepatocellular carcinoma: A case-control study 179
Infezione occulta da virus dell'epatite B 175
Quantificazione e biodegradazione del carico inquinante di liquami provenienti da industrie alimentari 174
Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology : a case-control study 171
Prevalence of S-gene mutants of hepatitis B virus in Italian blood donors and patients with chronic HBV infection 170
Hepatitis B virus S-gene mutants in HBsAg positive blood donors and in patients with hepatocellular carcinoma and controls with overt or occult HBV infection 168
Association between HLA DQB1*03 and HBV-related hepatocellular carcinoma 168
Hepatitis G and C virus coinfection in children 166
Il ruolo della vaccinazione nella prevenzione dell'epatite virale di tipo B: Aspetti storici ed attualita 166
Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma : the role of HCV genotypes and the synergism with hepatitis B virus and alcohol 165
Antibodies to hepatitis C virus in community-acquired acute non-A, non-B hepatitis 165
Acquisizione dell'infezione da cytomegalovirus in neonati trasfusi nelle prime settimane di vita 163
Infezione occulta da virus dell'epatite B in donatore di cellule staminali emopoietiche e ricevente con mieloma multiplo 161
Acute non-A, non-B hepatitis in Italy: a 16-year prospective epidemiological study. The possible role of hepatitis C virus 160
Vertical transmission of hepatitis C virus in infants born to HCV and HIV seropositive mothers 159
Hepatitis C virus genotype in anti-HCV-positive hemodialysed patients 157
Long-Term Surveillance of Allogeneic and Autologous Hemopoietic Stem Cell Transplant Recipients Affected by Primary Occult Hepatitis B Virus Infection 154
HBV, HDV and HIV infections in 242 drug addicts: two-year follow-up. 152
Prevalence of GB virus-C/hepatitis G virus infection in patients with cryptogenic chronic liver disease and in patients with primary biliary cirrhosis or Wilson's disease 149
A case-control study on GB virus C/hepatitis G virus infection and hepatocellular carcinoma 149
Alpha-Interferon therapy in patients with HCV and HGV coinfection : changes in quantitative HCV and HGV RNA levels 149
Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection? 146
Profilo sierologico dell'epatite C acuta e cronica post-trasfusionale 146
Prevalenza dell'infezione da Rotavirus in bambini ospedalizzati per gastroenterite acuta 146
La variabilità genetica del virus dell'epatite B 145
Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake and hepatolithiasis : a case-control study in Italy 145
Comparative study of some culture media for use in determination of coliform organisms 145
Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies 144
A hepatitis B vaccination programme in a group of dental practitioners 144
L'infezone da virus dell’epatite B nel personale di odontoiatria 144
A long term study of hepatitis G virus coinfection in chronic hepatitis B 144
Prophylaxis against HCV recurrence after liver transplantation : effect of interferon and ribavirin combination 143
Prevalence of 1762T 1764A mutations in the basic core promoter of HBV isolated from patients with hepatocellular carcinoma and controls 143
Hepatitis C outbreak in health-care workers partecipating in pharmacokinetic studies: biochemical, virological and histological outcome 143
Prevalence of markers to hepatitis B virus in dentists in eastern Lombardy 143
Reattività anticorpali anti-HBcAg discordanti tra metodiche sono predittive per la presenza di infezioni occulte da HBV? 142
A case-control study on a novel DNA virus (TT virus) infection and hepatocellular carcinoma 141
Natural history of chronic hepatitis C in children 140
HIV antibody screening and confirmatory testing of Italian blood donors. One-year experience of a reference center 140
Antibody to hepatitis C virus in cryptogenic chronic liver disease 139
Antibody to hepatitis C virus in post-transfusion hepatitis 138
Screening per anticorpi anti-HIV in donatori di sangue della Lombardia negli anni 1986- 1987 138
Alcohol and hepatocellular carcinoma : the effect of lifetime intake and hepatitis virus infections in men and women 138
HCMV INFECTION DIAGNOSIS BY DETECTION OF VIRAL DNA BY PCR IN SERUM OF PLASMA 137
Hepatitis C virus genotypes in patients with essential mixed cryoglobulinemia 137
Sulla presenza di virus poliomielitici e di altri enterovirus nei liquami di fogna 137
Primary liver cancer and occupation in men : a case-control study in a high-incidence area in Northern Italy 136
Dual HIV-1/HIV-2 reactivity in Italian i.v. drug abusers re-evaluated by synthetic peptide spot-test 136
The prevalence of HCV infection in a cohort of pregnant women, the related risk factors and the possibility of vertical trasmission 135
Consensus interferon (CIFN) in combination with ribavirin (RBV) for naive patients with chronic hepatitis C : a multicenter study 135
Response to interferon treatment in patients with chronic hepatitis and HCV/HGV coinfection 135
Antibodies to hepatitis C virus in children with acute or chronic viral hepatitis 134
Detection of antibody to HIV env glycoprotein in blood donors with indeterminate results on Western blotting 133
Occult Hepatitis B in patients with hepatocellular carcinoma and controls with and without hepatitis C virus infection 133
Liver disease in anti-HBe positive chronic HBsAg carriers and hepatitis C virus 133
Changes of antibody titer to hepatitis C virus during Interferon therapy of cryptogenic chronic active liver disease 133
Hepatitis B and C virus infection, alcohol drinking and hepatocellular carcinoma : a case-control study in Italy 132
Hepatitis C virus genotypes : distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe 132
Infezione occulta da virus dell’epatite B in pazienti con epatocarcinoma e controlli con o senza infezione da HCV 132
Efficacy and safety of consensus interferon (CIFN) plus ribavirin (RBV) for naive patients with chronic hepatitis C (CHC) : final report of a pilot study 130
Hepatitis C virus (HCV) in lymphocyte subsets and in B lymphocytes expressing rheumatoid factor cross-reacting idiotype in type II mixed cryoglobulinemia 129
Anti-HCV response in post-transfusion hepatitis (PTH). 129
Influence of GB virus-C/hepatitis G virus infection on the long term course of chronic hepatitis B 128
La profilassi immunitaria dell’epatite di tipo A: chi e come vaccinare 128
Febbre tifoide e infezioni da paratifi : andamento in Italia nell'ultimo decennio 127
Quantitation and typing of hepatitis C Virus RNA in patients on interferon and ribavirin prophylaxis after liver transplantation 127
Alcohol consumption, alcohol dehydrogenase 3 polymorphism and hepatocellular carcinoma : a case-control study 126
HIV-1 and HIV-2 infections in Italian AIDS/ARC patients 126
Effect of hepatitis C genotype on mother-to-infant transmission of virus 126
Fecal excretion of poliovirus in subjects subjected to antipoliomyelitis vaccination 124
Evolutionary and molecular aspects of surface antigen (HBsAg) gene mutants in blood donors with occult Hepatitis B virus infection 124
Significance of hepatitis C virus genotypes and viral load in patients with "essential" mixed cryoglobulinemia 123
Hepatitis C virus infection and chronic liver disease in children with leukemia in long-term remission 123
Environmental distribution of Salmonella. 2.Research on the coastal sea water of the city of Pesaro 122
Effetto della terapia antiretrovirale sulla viremia da HCV e sull'epatite C in una coorte di pazienti HIV positivi 122
Profilassi con Interferone e ribavirina in pazienti HCV-RNA postivi sottoposti a trapianto di fegato: una nuova strategia contro la recidiva di epatite C 122
A case-control study on family history of liver cancer as a risk factor for hepatocellular carcinoma in North Italy : Brescia HCC Study 121
A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis C 120
Totale 15.784
Categoria #
all - tutte 50.434
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.434


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021663 0 0 0 0 0 0 0 0 0 0 538 125
2021/20221.125 53 25 16 118 46 60 76 49 100 163 141 278
2022/20231.641 218 132 113 259 211 384 24 70 150 24 43 13
2023/2024979 19 81 22 15 140 25 22 267 12 145 120 111
2024/20252.450 86 369 26 329 285 22 52 287 107 125 222 540
2025/20264.763 582 227 594 384 428 357 477 363 632 460 259 0
Totale 20.870